Dermata Therapeutics Inc. (DRMAW) Technical Exchange News April 01, 2025, 18:35 UTC 52 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Aptose Biosciences Inc (APTO) Technical Exchange News April 01, 2025, 18:35 UTC 53 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
FORESIGHT (FRSX) Technical Exchange News April 01, 2025, 04:25 UTC 56 0 comments FORESIGHT (FRSX) was added to the list of traded instruments on TASE exchange Comment Full text
Connect Biopharma Holdings Ltd (CNTB) Technical Exchange News April 01, 2025, 03:03 UTC 55 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
CNS Pharmaceuticals Inc. (CNSP) Technical Exchange News April 01, 2025, 03:03 UTC 54 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Biodesix Inc (BDSX) Technical Exchange News April 01, 2025, 03:03 UTC 57 0 comments NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
CNS Pharmaceuticals Inc. (CNSP) Technical Exchange News March 31, 2025, 20:04 UTC 54 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal. Comment Full text
Connect Biopharma Holdings Ltd (CNTB) Technical Exchange News March 31, 2025, 20:04 UTC 53 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
Biodesix Inc (BDSX) Technical Exchange News March 31, 2025, 20:04 UTC 53 0 comments NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient. Comment Full text
23andMe Inc (ME) Technical Exchange News March 31, 2025, 07:49 UTC 54 0 comments 23andMe Inc (ME) was removed from the list of traded instruments on NASDAQ exchange Comment Full text